| Literature DB >> 32260589 |
Yeyetzi C Torres-Ugalde1, Angélica Romero-Palencia2, Alma D Román-Gutiérrez3, Deyanira Ojeda-Ramírez4, Rebeca M E Guzmán-Saldaña2.
Abstract
Caffeine is the most consumed psychostimulant worldwide. Its use among children is controversial. Although it produces an increase in brain activity, it could hamper growth and development in young consumers. Therefore, the aim of this review was to recognize changes produced by caffeine in children under 12 years of age and to identify the relevant alterations and the conditions of their occurrence. A systematic review of the literature was carried out using PRISMA. Initially, 5468 articles were found from the EBSCO, ScienceDirect, PubMed, and Clarivate Analytics databases. In this review, were retained 24 published articles that met the inclusion criteria. The results obtained showed that caffeine consumption hampers children's growth and development. In contrast, it supports the activation of the central nervous system and brain energy management.Entities:
Keywords: caffeine; children; development; growth; health effects; psychostimulant
Year: 2020 PMID: 32260589 PMCID: PMC7177467 DOI: 10.3390/ijerph17072489
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Steps for a systematic review of literature.
Figure 2Search criteria for information and keywords (KW).
Figure 3Process of systematic review of the literature.
General summary of the characteristics of the experimental studies analyzed.
| Characteristic | Number of Studies ( |
|---|---|
|
|
|
| 2008–2009 | 5 |
| 2010–2011 | 5 |
| 2012–2013 | 2 |
| 2014–2016 | 5 |
| 2016–2017 | 5 |
| 2018 | 1 |
|
|
|
| Concept | 3 |
| Arousal | 2 |
| Exercise | 2 |
| Sleep | 5 |
| Behavior | 4 |
| Newborns | 7 |
Study categories of effects produced by caffeine in children.
| Positive Effects ( | Negative Effects ( |
|---|---|
| Arousal ( | Sleep disorders ( |
| Physical activation ( | Affective disorders ( |
| Treatment of respiratory disorders in newborns ( |
Analysis of studies on caffeine intake perception, according to the PICOS 1 method.
| Study | Participants | Interventions | Comparisons | Outcomes | S. Design |
|---|---|---|---|---|---|
| Bucher and Siegrist (2015) [ | 100 children with one parent ( | Beverage-sorting task | Product classification in healthy and unhealthy | Negative perception of caffeine | Cross- sectional |
| Wierzejska et al. (2016) [ | 329 children: ages 11–13 | Food frequency questionnaire | Personal interviews | Negative perception of caffeine | Face-to-face interview |
| Visram et al. (2017) [ | 37 children, 2 groups: ages 10–11 ( | Semi-structured focus groups | Personal opinions | Negative perception of caffeine | Qualitative, based on data |
1 PICOS = P: participants; I: interventions; C: comparisons; O: outcomes; S: study design.
Description of analyzed studies on arousal, according to the PICOS 1 method.
| Study | Participants | Interventions | Comparisons | Outcomes | S. Design |
|---|---|---|---|---|---|
| Barry et al. (2009) [ | 30 children; ages 8–13 | Caffeine administration: 80 mg (1.3–3.3 mg/kg/day) | Caffeine vs. placebo: electrodermal activity and EEG 2 changes | Caffeine increases arousal | Randomized double blind placebo control cross-over trial |
| Barry et al. (2012) [ | 18 ADHD children; ages 8–13. | Caffeine administration: 80 mg caffeine | Caffeine vs. placebo: electrodermal activity | Caffeine increases arousal | Randomized double blind placebo control cross-over trial |
1 PICOS = P: participants; I: interventions; C: comparisons; O: outcomes; S: study design. 2 EEG = Electroencephalogram.
Description of analyzed studies on physical activation, according to the PICOS 1 method.
| Study | Participants | Interventions | Comparisons | Outcomes | S. Design |
|---|---|---|---|---|---|
| Turley, et al. (2008) [ | 40 children; ages 7–9 | Caffeine administration: 1, 3, and 5 mg/kg/day | Caffeine vs. placebo: ergometry, blood pressure, and cardiac frequency 60 minutes before exercise | Caffeine increases BP 2 and reduces HR 3 | Randomized double blind placebo control counter-balanced |
| Turley et al. (2014) [ | 26 children (male); ages 8–10 | Caffeine administration: 1, 3, and 5 mg/kg/day | Caffeine vs. placebo: static handgrip and ergometry | Caffeine provides greater strength and physical performance | Randomized double blind placebo control counter-balanced |
1 PICOS = P: participants; I: interventions; C: comparisons; O: outcomes; S: study design. 2 BP = Blood pressure. 3 HR = Heart rate.
Description of analyzed studies on respiratory disorders, according to the PICOS 1 method.
| Study | Participants | Interventions | Comparisons | Outcomes | S. Design |
|---|---|---|---|---|---|
| Khalil et al. (2008) [ | 72 children in 2 groups: experimental | Caffeine benzoate administration: 20 mg/kg IV | Caffeine vs. placebo: presence of adverse respiratory events post-extubation | Caffeine improves respiratory function | Randomized double blind placebo control |
| Doyle et al. (2010) [ | 70 preterm infants aged 10 days | Caffeine citrate administration: 20 mg/kg | Caffeine vs. placebo: IRM differences | Caffeine improves development of white matter | Randomized placebo control |
| Gray et al. (2011) [ | 287 infants under 30 WOG2 suffering apnea of prematurity | Caffeine citrate administration: group 1 = 5 mg/kg; group 2 = 20 mg/kg | Low dose vs. high dose: development and cognition study 1 year after; temper study 2 years after. | Caffeine in apnea of prematurity does not affect cognition nor behavior | Multicenter randomized controlled trial |
| Boia et al. (2014) [ | 84 pre-term infants < 32 WOG 2 and < 1500 g suffering apnea of prematurity | Caffeine citrate administration: 5 mg/kg/day. Theophylline administration: 3 mg/kg/day | Caffeine vs. theophylline: adverse effects | Caffeine causes fewer adverse effects tan theophylline in apnea of prematurity | Retrospective analysis |
| Doyle et al. (2014) [ | 1433 infants suffering apnea of prematurity and who developed cerebral palsy | Caffeine citrate administration at therapeutics doses; test battery for movement evaluation; Wechsler for preschoolers; primary scale of intelligence III | Caffeine vs. placebo | Caffeine leads to fewer coordination disorders | Randomized and retrospective controlled trial |
| Khurana et al. (2017) [ | 240 infants aged 18–24 months and corrected apnea of prematurity | Caffeine citrate administration: 20 mg/kg/day. Theophylline administration: 5 mg/kg/day | Caffeine vs. theophylline: cognitive performance | Caffeine in apnea of prematurity improves cognitive performance and reduces motor deficiencies | Randomized and retrospective controlled trial |
| Mürner-Lavanchy et al. (2018) [ | 870 children; age 11. | Caffeine citrate administration 20 mg/kg | Caffeine vs. no caffeine: intelligence, | Caffeine in apnea of prematurity | Randomized double blind |
1 PICOS = P: participants; I: interventions; C: comparisons; O: outcomes; S: study design. 2 WOG = Weeks of gestation.
Description of analyzed studies on sleep disorders, according to the PICOS 1 method.
| Study | Participants | Interventions | Comparisons | Outcomes | S. Design |
|---|---|---|---|---|---|
| Warzak et al. (2011) [ | 201 children; ages 5–12 | Caffeine intake: 52–109 mg/day | Evaluation of enuresis and sleep history | Caffeine reduces total sleeping time | Cross-sectional |
| Calhoun et al. (2011) [ | 77 children with excessive day drowsiness; ages 5–12 | Caffeine intake questionnaire | Caffeine vs. no caffeine 2: polysomnography | Caffeine is not associated to excessive day drowsiness | Cross-sectional |
| Calamaro et al. (2012) [ | 625 children; ages 6–10 | Caffeine intake: 1–5 cans of soda or cups of coffee per day | Low caffeine intake vs. high caffeine intake by frequency questionnaires | Caffeine produces 15 minutes less of sleep per night | Cross-sectional |
| Katz, et al. (2014) [ | 210 children; ages 9–15 | Drug testing | Caffeine detected or undetected by drug testing | Caffeine increases start of sleep by 4 minutes | Retrospective analysis |
| Watson et al. (2017) [ | 309 children; ages 8–12 | Caffeine intake: 0–151 mg/day | Caffeine versus no caffeine | Caffeine is related to sleep disorders | Cross-sectional |
1 PICOS = P: participants; I: interventions; C: comparisons; O: outcomes; S: study design. 2 Other variables besides caffeine were considered in this study.
Description of analyzed studies on affective states, according to the PICOS 1 method.
| Study | Participants | Interventions | Comparisons | Outcomes | S. Design |
|---|---|---|---|---|---|
| Whalen et al. (2008) [ | 53 children and adolescents (30 with major depressive disorder); ages 7–17 | Caffeine intake questionnaires; structured diagnosis interviews | Caffeine vs. no caffeine: structured diagnostic interviews differences | Higher caffeine intake in major depressive disorder | Clinical evaluation longitudinal study |
| Luebbe and Bell (2009) [ | 135 children aged 10–12; 79 adolescents aged 15–17 | Frequency of consumption questionnaire of caffeine; depression inventory for youth; treatment of anxiety inventory for children | Low and high caffeine consumption: mood differences | Young children who consume higher doses proportionally to weight are more sensitive to caffeine | Cohorts |
| Benko et al. (2011) [ | 51 children; aged 9–12 | Nutrition-behavior inventory; depression inventory for youth; child behavior checklist | Low vs. high caffeine intake: mood differences | Caffeine increases depressive symptoms | Longitudinal |
1 PICOS = P: participants; I: interventions; C: comparisons; O: outcomes; S: study design.